FAGR Fagron SA

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 31 October 2025 – 6PM CET

Fagron’s share buy-back program: Weekly update

In the period from 27 October 2025 through 31 October 2025, Fagron purchased 46,000 of its owns shares at an average price of €20.5831 per share corresponding to a total amount of €946,821.80.

These purchases are part of the share buy-back program of up to 200,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme, which was announced on 9 October 2025.

The total number of own shares purchased to date is 111,000.

More information, including a detailed overview of the purchase transactions under this program, is available on our .

Financial calendar

12 February 2026                Full year results 2025

9 April 2026                         Trading update first quarter 2026

11 May 2026                        Annual General Meeting 2025

30 July 2026                         Half year results 2026

8 October 2026                        Trading update third quarter 2026

Further information

Ignacio Artola

Global Investor Relations Leader

About Fagron

Fagron is the leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 35 countries around the world.

The Belgian company Fagron NV is based on Venecoweg 20A in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed through the Dutch company Fagron BV. Fagron BV’s head office is located in Rotterdam.

Important information regarding forward-looking statements

Certain statements in this press release may be deemed to be forward-looking. Such forward-looking statements are based on current expectations and are influenced by various risks and uncertainties. Consequently, Fagron cannot provide any guarantee that such forward-looking statements will, in fact, materialize and cannot accept any obligation to update or revise any forward-looking statement as a result of new information, future events or for any other reason.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

        

Attachment



EN
31/10/2025

Underlying

FAGRFagron SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

ING Helpdesk
  • ING Helpdesk
FAGR FAGRON SA
EVS EVS Broadcast E... ... (+6)

Benelux Morning Notes

Colruyt: Only 5 stores left to divest in France. EVS: Lower end of the range becomes the base case, on longer lead times. Fagron: Two EMEA acquisitions and California license for FSS. Kinepolis: “Wicked” achieves solid box office. OCI: Divesting Rotterdam ammonia terminal for €290m. Prosus: 1HFY26 results – on track

FAGR FAGRON SA
EVS EVS BROADCAST EQUIPMENT SA
COLR ETABLISSEMENTEN FRANZ COLRUYT N.V.
OCI OCI NV
KIN KINEPOLIS GROUP NV
PRX PROSUS N.V. CLASS N
11/24/25 November 24, 2025 1 EN
Guy Sips ... (+6)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Mathijs Geerts Danau
  • Thibault Leneeuw
  • Wim Lewi
FAGR FAGRON SA
EVS EVS BROADCAST EQUIPMENT SA
MONT MONTEA SCA
IVA INVENTIVA SA
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
SEQUA SEQUANA MEDICAL
ONWD ONWARD MEDICAL NV
11/24/25 November 24, 2025 1 EN
 PRESS RELEASE
Free
FAGR FAGRON SA

Fagron strengthens EMEA leadership with acquisitions in Poland and Hun...

Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 – 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business Fagron, the global leader in pharmaceutical compounding, has reinforced its EMEA position with the acquisitions of a book of business from Amara (Poland) and Magilab (Hungary). These deals support F...

November 24, 2025 1 EN
 PRESS RELEASE
Free
FAGR FAGRON SA

Fagron versterkt leiderschap in de EMEA-regio met overnames in Polen e...

Fagron versterkt leiderschap in de EMEA-regio met overnames in Polen en Hongarije en kondigt belangrijke ontwikkelingen aan voor de Noord-Amerikaanse activiteiten Gereglementeerde informatie - voorkennisNazareth (België)/Rotterdam (Nederland), 24 November 2025 – 07.00 uur CET Fagron versterkt leiderschap in de EMEA-regio met overnames in Polen en Hongarije en kondigt belangrijke ontwikkelingen aan voor de Noord-Amerikaanse activiteiten Fagron, wereldwijd marktleider in farmaceutische bereidingen, heeft zijn positie in de EMEA-regio versterkt door de overname van een klantenportefeuille va...

November 24, 2025 1 EN
 PRESS RELEASE
Free
FAGR FAGRON SA

Fagron completes share buy-back program

Fagron completes share buy-back program Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 14 November 2025 – 6PM CET Fagron completes share buy-back program In the period from 10 November 2025 through 14 November 2025, Fagron purchased 44,000 of its owns shares at an average price of €20.7208 per share corresponding to a total amount of €911,717.00. A total of 200,000 Fagron shares have been repurchased under the buy-back program at an average price of € 20.6805 per share, corresponding to a total amount of € 4,136,093.00. The share buy-back program was announced on ...

November 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch